West Bloomfield, Michigan — February 22, 2017 — LSPediA LLC, a leading software and service provider for the pharmaceutical industry, announced today that Vitruvias Therapeutics, a privately-funded generic pharmaceutical company located in Auburn, Alabama, selected LSPediA to provide Drug Supply Chain Security Act (DSCSA) and serialization consulting services.
Vitruvias is committed to bringing difficult-to-formulate and manufacture topical and injectable generic drugs to market. Specializing in products with a moderate to high barrier entry, Vitruvias is able to overcome manufacturing complexities and raw material sourcing issues through strategic partnerships.
LSPediA will provide overall serialization project management, serialization advisory, and vendor management services, and will assist with any additional business activities relevant to serialization. Through these activities, LSPediA will ensure Vitruvias Therapeutics meets compliance deadlines for DSCSA requirements, industry standards, and customer needs.
“We’re excited to be working with Vitruvias Therapeutics, a well-respected and forward-thinking pharmaceutical company,” said Riya Cao, CEO, LSPediA. “We are delighted to offer our expertise and knowledge around serialization to help Vitruvias achieve success in DSCSA compliance.”
About Vitruvias Therapeutics
Vitruvias is a privately-funded generic pharmaceutical company founded in 2013. The primary focus of the company is the development and marketing of niche injectable and topical generic pharmaceutical products. The highly skilled team at Vitruvias has expertise in all aspects of the pharmaceutical industry, including product development, licensing, regulatory affairs, marketing, financial analysis, distribution, managed care, trade relations and sales.
About LSPediA – Life Sciences Solutions
LSPediA is a leading provider of enterprise software and services designed for pharmaceutical manufacturers, wholesale distributors, and dispensers. With LSPediA, customers can better implement serialization and aggregation processes to meet global regulations, DSCSA requirements, and future track-and-trace mandates.
For additional information, contact: Julianne Jahn [email protected]